Why the study?
Evaluating the accuracy of machine learning algorithms is needed to identify the most efficient predictive model for diagnosing cardiovascular disease from patient health history.
Does a support vector machine classifier improve the prediction of cardiovascular disease compared to other supervised machine learning algorithms?
Does a support vector machine classifier improve the prediction of cardiovascular disease compared to other supervised machine learning algorithms?
Support vector machine algorithms demonstrate superior performance metrics compared to other common supervised machine learning models for predicting cardiovascular disease.
SVM may enhance CVD prediction; hypothesis-generating, needs prospective validation before clinical use.
In recent years, the application of machine learning models is becoming more prevalent in identifying, predicting, and diagnosing cardiovascular disease (CVD). CVD is known to be the top cause of death globally and about 17.9 million lives are lost each year due to CVD, according to the World Health Organisation. Studying the accuracy of machine learning algorithms is significant in identifying a predictive model which is most efficient in diagnosing cardiovascular diseases in patients, on the basis of their health history. In this research, the CVD dataset (accessible from Kaggle), which has 70,000 records of different patients' case histories and 11 attributes for each patient, has been used. With the aim of identifying the most efficient model, different supervised machine learning algorithms are built and compared, implementing the decision tree classifier, the random forest classifier, K-nearest neighbors, and support vector machine classifier using Python 3.7. The results showed that the support vector machine predictive model gives a better result than the other models, in terms of the accuracy, Area Under the Curve (AUC) score and F1 score. The contribution of this research will be the application of a predictive model through which CVD can be identified, diagnosed, and treated at early stages.
No takes yet. Share an insight, caveat, or question.
Jatin Gupta (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: